Microbiome Drug Development in Asia Infographic
Covered in the Infographic:
- An overview of the Asian Microbiome market and it’s significance within the wider global space
- Analysis of the 160+ Asian companies tracked on Beacon Microbiome by company type and size, along with a look at funding type and potential deal value
- A deep dive into the most prominent disease targets and therapeutic classes in the Asian market
To learn more about the infographic and how Beacon Microbiome can enhance your data needs and provide fast insights, please book a research session below or contact us directly on beacon@hansonwade.com.
You May Also Be Interested In…
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
